Integrin α5 promotes migration and cisplatin resistance in esophageal squamous cell carcinoma cells

Cisplatin, as one of the front-line chemotherapeutic drugs, is employed for the treatment of esophageal squamous cell carcinoma (ESCC). However, the occurrence of cisplatin resistance and metastasis remain as challenges in clinical therapy. To investigate the mechanism involved in cisplatin resistan...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Am J Cancer Res
Egile Nagusiak: Hou, Sicong, Jin, Weiguo, Xiao, Weiming, Deng, Bin, Wu, Dacheng, Zhi, Jiehua, Wu, Keyan, Cao, Xiaowei, Chen, Shuai, Ding, Yanbing, Shi, Hongcan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: e-Century Publishing Corporation 2019
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6943361/
https://ncbi.nlm.nih.gov/pubmed/31911861
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak